Table 2.
Combination therapy | Abatacept 10 mg/kg/4 weeks + MTX |
Adalimumab 40 mg/2 weeks + MTX | |
Certolizumab pegol 200 mg/2 weeks + MTX | |
Etanercept 2 × 25 mg/week + MTX | |
Golimumab 50 mg/4 weeks + MTX | |
Infliximab 3 mg/kg/8 weeks + MTX | |
Rituximab 2 × 1000 mg + MTX | |
Tocilizumab 8 mg/kg/4 weeks + MTX | |
Controls – DMARD monotherapy (= MTX or sulfasalazine) | |
Monotherapy | Adalimumab 40 mg/2 weeks |
Certolizumab pegol 200 mg/2 weeks | |
Etanercept 2 × 25 mg/week | |
Tocilizumab 8 mg/kg/4 weeks | |
Control (= placebo or sulfasalazine) |
Abbreviations: DMARD, disease-modifying antirheumatic drug; MTX, methotrexate.